** Downtime Notice ** We are going to have a brief downtime of a few minutes in the 9pm EST hour on Tuesday, September 23. | If you’re a federal employee and have questions about continuing coverage, please speak to your Patient Benefits Specialist and visit our insurance page here: virginiacancerspecialists.com/insurance/.
A selective, orally bioavailable, pyrimidinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. In addition to its effect on glucose levels, alogliptin may inhibit inflammatory responses by preventing the toll-like receptor 4 (TLR-4)-mediated formation of proinflammatory cytokines. Check for active clinical trials using this agent. (NCI Thesaurus)
Related Posts
Recent Posts
